Zhigang Li
机构：Shanghai Chest Hospital · ORCID：0000-0001-5086-5334
发表论文 550 篇 · 总被引 7182 次 · h-index 38
代表论文
- Alleviated T cell exhaustion and SLC1A3-mediated stroma-remodelling dictate chemoimmunotherapy efficacy in oesophageal squamous cell carcinoma (2025 · Gut · 被引 3)
- Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in China (2026 · Diseases of the Esophagus · 被引 2)
- Neoadjuvant Immuno-Chemotherapy Versus Neoadjuvant Chemoradiotherapy in Locally Advanced Oesophageal Squamous Cell Carcinoma (2025 · European Journal of Cardio-Thoracic Surgery · 被引 2)
- KSR1 is a scaffold for the Hippo signaling pathway (2025 · Communications Biology · 被引 1)
- Preoperative chemoimmunotherapy vs chemoradiotherapy in cT4 ESCC: a multicenter retrospective study (2026 · European Journal of Surgical Oncology)
- Diagnostic performance of postoperative endoscopy versus water-soluble esophagram in detecting anastomotic leak after esophagectomy (2026 · Diseases of the Esophagus)